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Abstract
Inflammatory bowel disease (IBD) is considered to be the most common cause of vomiting and diarrhoea in dogs, and the
German shepherd dog (GSD) is particularly susceptible. The exact aetiology of IBD is unknown, however associations have
been identified between specific single-nucleotide polymorphisms (SNPs) in Toll-like receptors (TLRs) and human IBD.
However, to date, no genetic studies have been undertaken in canine IBD. The aim of this study was to investigate whether
polymorphisms in canine TLR 2, 4 and 5 genes are associated with IBD in GSDs. Mutational analysis of TLR2, TLR4 and TLR5
was performed in 10 unrelated GSDs with IBD. Four non-synonymous SNPs (T23C, G1039A, A1571T and G1807A) were
identified in the TLR4 gene, and three non-synonymous SNPs (G22A, C100T and T1844C) were identified in the TLR5 gene.
The non-synonymous SNPs identified in TLR4 and TLR5 were evaluated further in a case-control study using a SNaPSHOT
multiplex reaction. Sequencing information from 55 unrelated GSDs with IBD were compared to a control group consisting
of 61 unrelated GSDs. The G22A SNP in TLR5 was significantly associated with IBD in GSDs, whereas the remaining two SNPs
were found to be significantly protective for IBD. Furthermore, the two SNPs in TLR4 (A1571T and G1807A) were in
complete linkage disequilibrium, and were also significantly associated with IBD. The TLR5 risk haplotype (ACC) without the
two associated TLR4 SNP alleles was significantly associated with IBD, however the presence of the two TLR4 SNP risk alleles
without the TLR5 risk haplotype was not statistically associated with IBD. Our study suggests that the three TLR5 SNPs and
two TLR4 SNPs; A1571T and G1807A could play a role in the pathogenesis of IBD in GSDs. Further studies are required to
confirm the functional importance of these polymorphisms in the pathogenesis of this disease.
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Introduction
The healthy gut is able to regulate inflammatory responses to
commensal bacteria and food antigens whilst maintaining the
capacity to respond to pathogens [1,2,3]. This distinction relies on
Toll-like receptors (TLRs) which are ideally situated on intestinal
epithelia cells and recognise microbe associated molecular patterns
(MAMPs) [4]. TLR2, TLR4 and TLR5 are particularly associated
with recognition of lipoproteins, lipopolysaccharide and flagellin
respectively[4].Abreakdowninthishomeostaticresponsemaylead
to inflammatory bowel disease (IBD) in people as well as in dogs [1].
IBD is a chronic debilitating disease and occurs in both people
anddogs. Indogs,itrepresents a groupofdisorderscharacterisedby
chronic gastro-intestinal signs, with histological evidence of
inflammation in the lamina propria of the small intestine, large
intestineorboth[5].Inpeople,IBDconsistsofCrohn’sdisease(CD)
andulcerativecolitis(UC)[6].Inflammation associatedwith CDcan
occur in any area of the intestinal tract, although the terminal ileum
is most commonly affected, whereas UC is confined to the colon [6].
CD typically involves granuloma formation and commonly involves
the whole intestinal wall, while inflammation in UC is usually
restricted to the superficial layers [6]. Canine IBD is a diagnosis of
exclusion and in both dogs and people histopathology of intestinal
sections are needed to make a definitive diagnosis [5,6].
Immunosupressive therapy is the mainstay treatment for both
human IBD and canine IBD patients [5,6].
Although the exact aetiology of IBD is unknown it is considered a
multifactorial disease with the mucosal immune system, microbiota,
genetics and environment all playing a role[6,7,8,9]. It is likely that
human and canine IBD share similar aetiological factors as studies
have already highlighted the importance of TLRs in IBD in both
species. In human IBD, TLR 2,4 and 6 have been shown to be up-
regulated in the intestine [10,11,12], whilst some studies have
documented a down-regulation of TLR5[13,14]. Similar to this, we
have recently shown an upregulation of TLR 2,4 and 9 expression
in the duodenum and colonic mucosa at the mRNA level in dogs
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15740with IBD of different breeds [15,16]. Also, specific to German
shepherd dogs (GSDs) with IBD, TLR4 was shown to be
upregulated and TLR5 downregulated at the mRNA level [17].
In people a number of genetic polymorphisms have been
reported to play a role in the pathogenesis of IBD, interestingly
most of these genes are involved in the innate immune mechanism
and primary defence against bacteria. Polymorphisms in the
nucleotide oligomerisation domain 2 (NOD2) are considered the
most important genetic susceptibility factor for CD, with approx-
imately 20–40%ofall patientscarrying variantsofthisgene [18,19].
However, polymorphisms in other innate immune receptors such as
TLRs [20,21,22], the autophagy pathway (e.g. ATG16L1 and
IGRM) [23,24], cytokines (e.g. IL-10) [25] and their receptors (e.g
IL23R) [26] and in human defensin (e.g. beta defensin 1) [27] genes
have also been shown to be associated with IBD in people.
To date no genetic studies have been carried out in canine IBD.
However, genetics are thought to play a fundamental role as
certain breeds are susceptible to this disease. Retrospective analysis
of the medical records at the Royal Veterinary College (RVC),
UK, dating back over 10 years, revealed 555 dogs diagnosed with
IBD. The GSD breed was the most common breed identified and
represented 10% of the dogs diagnosed. We have previously
demonstrated restriction of TLR5 allele frequencies in this breed
by genetic analysis using microsatellite markers [28]. Furthermore,
analysis of single nucleotide polymorphisms (SNPs) within the
TLR5 gene demonstrated a significant difference in the GSD
population compared to the general dog population [28]. This
provides evidence that the underlying genetic make-up of this
breed may be responsible for their increased susceptibility to IBD.
Comparisons of the canine and human TLR genetic sequences
show a high degree of homology; this suggests that similar
polymorphisms in the TLR genes seen in people with IBD may
exist in dogs. Therefore, a candidate approach was used to test the
hypothesis whether SNPs in genes for TLR2, TLR4 and TLR5 in
GSDs are associated with IBD. We show that the TLR5 G22A,
C100T, T1844C and the TLR4 SNP A1571T and G1807A SNPs
are significantly associated with IBD in GSDs.
Results
Mutational Analysis of TLR2/TLR4 and TLR5 genes
A mutational analysis of 10 GSDs with IBD was carried out to
determine the number and nature of non-synonymous single
nucleotide polymorphisms (SNPs) present in the TLR2, TLR4 and
TLR5 gene. This analysis revealed that there were no non-
synonymous SNPs in the coding region of the TLR2 gene. Four
non-synonymous SNPs were identified in the TLR4 exons; T23C
(ENSCAFT00000005653), G1039A (not reported on the Ensembl
web server), A1571T (ENSCAFT00000005653) and G1807A
(ENSCAFT00000005653) and three non-synonymous SNPs were
identified in the TLR5 exon; G22A (ENSCAFT00000018059),
C100T (ENSCAFT00000018059) and T1844C (ENSCAFT-
00000018059). All non-synonymous SNPs identified in the
TLR4 and TLR5 gene resulted in a change in the class of amino
acid coded (Table 1).
Case-control association study of TLR4 and TLR5 SNPs in
German shepherd dogs
An association study was carried out to assess the significance of
the non-synonymous SNPs identified by mutational analysis in
GSDs with IBD. The case group consisted of 55 unrelated GSDs;
38 diagnosed with IBD at the Royal Veterinary College (RVC),
UK and 17 diagnosed with IBD at the Small Animal Teaching
Hospital, University of Liverpool (Table 2). The control
population consisted of 61 GSDs, of which 47 dogs were
diagnosed with non-inflammatory disease at the RVC, UK and
14 healthy GSDs (Table 2). The most common diagnosis for the
group of GSDs diagnosed with non-inflammatory disease was
neoplasia. Nineteen dogs fell into this latter category, 18 had
neurological disease, three had musculoskeletal disease, two had
gastrointestinal disease and there was one dog in the following
aetiological categories; cardiovascular, dermatological and uro-
genital. Two dogs had other diseases that did not fit the above
aetiological categories: one had suffered a road traffic accident,
whilst the other had post-ovariohysterrectomy haemorrhage
(Table 3).
The minor allele frequencies for all the SNPs were .10%
(Table 4). The presence of Hardy-Weinberg equilibrium was
tested using the exact Hardy-Weinberg test [29] using the
SNPSTATS programme [30](http://bioinfo.iconcologia.net/in-
dex.php?module=Snpstats). Only three of the SNP alleles; TLR5
G22A, TLR4 T23C and TLR4 G1039A were in Hardy Weinberg
equilibrium (P.0.05).
The significance of the SNP alleles was determined using the
Haploview software package (version 4.1; http://www.broad.mit.
edu/personal/jcbarret/haplo/). All TLR5 SNP alleles and two of
the TLR4 SNP alleles (A1571T and TLR4 G1807A) were found
to be significantly associated with IBD in GSDs (Table 4).
To assess the importance of the identified associated SNP alleles
in their genotype forms for association in IBD, five inheritance
models (co-dominant, dominant, recessive, over-dominant and
additive) were applied for statistical analysis to assess which one
Table 1. Amino-acid change coded by non-synonymous single nucleotide polymorphisms in the canine TLR4 and TLR5 gene.
SNP Amino-acid wild-type Amino-acid change associated with SNP
TLR4 T23C Valine Alanine
G1039A Alanine Threonine
A1571T Valine Glutamic acid
G1807A Lysine Glutamic acid
TLR5 G22A Alanine Threonine
C100T Arginine Cystiene
T1844C Leucine Serine
Amino-acid change coded by the non-synonymous single nucleotide polymorphisms (SNPs) identified in the TLR4 and TLR5 gene by mutational analysis of ten German
shepherd dogs with inflammatory bowel disease (non-polar amino acids-valine, alanine and leucine, basic amino-acids-lysine and arginine, acidic amino-acid-glutamic
acid and polar amino-acids-threonine, cystiene and serine).
doi:10.1371/journal.pone.0015740.t001
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the Akaike information criteria (AIC) and the Bayesian informa-
tion criteria (BIC), with the model with the lowest values being the
best fit [31,32].
For the two TLR4 SNPs; A1571T and G1807A the recessive
model was the best fit, where two copies of T and A respectively
are necessary to increase the risk of developing IBD in GSDs
(Table 5).
For the TLR5 G22A SNP, the best fit model was the additive
model, where having each copy of A modifies the risk of
developing IBD in an additive form. As a consequence, the
homozygous AA GSD has a double risk of developing IBD
compared to the GA genotype (p,0.0001, OR (95% CI)=8.51
(2.71–26.70) (Table 6). However, the AIC and BIC for the
dominant model was also low and very close to the additive model
and, therefore, could also be a good fit model. For both the TLR5
SNPs C100T and T1844C, the T allele was significantly protective
for IBD, and exerted a dominant effect (p,0.0001, OR=0.19
[0.09–0.44, 95% CI]: p=7e-04, OR=0.25 [0.11–0.58, 95% CI],
respectively; Table 6). Based on univariate analysis, age and sex
were not significantly associated with SNP outcome (p.0.05).
The statistical correlation between different SNPs on the same
gene was calculated to determine the inheritance pattern of alleles
and the possible haplotype combinations. There was evidence of
linkage disequilibrium (LD) between the SNPs in the TLR4 gene.
TLR4 A1571T and TLR4 G1807A showed complete linkage,
whereas TLR4 T23C and TLR4 G1039A showed no linkage
which is not unexpected as they are present on different exons
(Figure 1). There was also evidence of linkage between the three
SNPs in the TLR5 gene with the TLR5 C100T and TLR5
T1844C showing the most linkage (Figure 2). There was also
evidence of linkage amongst the other SNPs (Lod.3) (Figure 1
and 2).
LD analysis demonstrated significant linkage between SNPs on
the same gene therefore haplotype analysis was carried out to
determine their significance in IBD. The most significant
haplotype combination was with the TLR5 G22A SNP, without
the two protective TLR5 SNPs (C100T and T1844C) and with the
two TLR4 SNPs (A1571T and G1807A) (p,0.0001). However,
Table 2. Signalment of cases and controls.
Controls Cases P-value
Counts Proportions Counts Proportions
Sex Male 34 0.56 30 0.55 0.54
Female 27 0.44 25 0.45
Age 1–4 years 15 0.25 24 0.44 0.0017
5–9 years 36 0.59 21 0.38
.10 years 10 0.16 10 0.18
Signalment of 55 German shepherd dog (GSD) cases and 61 GSD controls included in the TLR4 and TLR5 association study of inflammatory bowel disease.
doi:10.1371/journal.pone.0015740.t002
Table 3. Disease phenotype of controls dogs.
Counts
Neurological Degenerative myelopathy 6
Idiopathic epilepsy 4
Intervertebral disc disease 4
Fibro-cartilaginous embolism 4
Musculo-skeletal Hip degenerative joint disease 2
Idiopathic generalised osteopenia 1







Nerve sheath tumour 1
Glial cell tumour 1
Cardiovascular Idiopathic pericardial effusion 1
Dermatological Peri-vascular dermatitis 1
Uro-genital Protein losing nephropathy 1
Other Road traffic accident 1
Bleeding post-spay 1
Healthy Blood donor 6
Recruited for study 8
Disease phenotype of 61 German shepherd dogs (GSDs) included in the control
group in the TLR4 and TLR5 association study of IBD using a SNaPSHOT
multiplex reaction (case=55 unrelated GSDs, control=61 unrelated GSDs; 47
GSDs with non-inflammatory disease and 14 healthy GSDs).
doi:10.1371/journal.pone.0015740.t003
Table 4. Single nucleotide polymorphism allele association






TLR5 G22A A 0.112 5.5414e
25
TLR5 C100T C 0.44 4.7128E
25
TLR5 T1844C C 0.466 0.0071
TLR4 T23C T 0.274 0.1013
TLR4 G1039A G 0.316 0.0926
TLR4 A1571T A 0.149 0.0282
TLR4 G1807A G 0.149 0.0282
Association of TLR4 and TLR5 single nucleotide polymorphism (SNP) alleles in a
case-control association study of inflammatory bowel disease in German
shepherd dogs (GSDs) carried out using a SNaPSHOT multiplex reaction
(case=55 unrelated GSDs, control=61 GSDs; 47 GSDs with non-inflammatory
disease and 14 healthy GSDs).
doi:10.1371/journal.pone.0015740.t004
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two TLR4 SNPs was significantly associated with IBD (p=0.029),
a haplotype combination containing the two associated TLR4
SNPs without the associated TLR5 risk haplotype (ACC) was not
statistically associated with IBD (p=0.67). Of the six dogs that
were homozygous recessive for the two associated TLR4 SNPs,
five of these dogs had the risk haplotype for the three SNPs in their
TLR5 gene (ACC).
Discussion
The importance of TLRs in the pathogenesis of IBD in both
people and dogs has been reported in the literature
[10,11,12,14,15,16]. Furthermore, SNPs in TLRs have been
shown to be associated with IBD in people [20,21,22,33,34].
However, no genetic studies looking at SNPs in TLRs in canine
IBD have been described. In this current study we identified three
non-synonymous SNPs in the TLR5 gene (G22A, C100T and
T1844C) and two non-synonymous SNPs in the TLR4 gene
(A1571T and G1807A) to be significantly associated with IBD in
GSDs.
Like all dog breeds the GSD has undergone selective breeding
[28] and this may reflect why all the associated SNPs, except one
(TLR5 G22A) were not in Hardy-Weinberg equilibrium. Addi-
tionally, for the TLR5 T1844C SNP the major allele, the T
reported on the Ensembl webserver was the minor allele in the
GSD population and was found to be protective for IBD. It is
possible that selective breeding in the GSD population has resulted
in loss of the protective effect of this major allele in the GSD
population compared to the general dog population thus making
them more susceptible to IBD. Similarly, for the TLR4 SNPs
A1571T and G1807, the major allele reported on the ensemble
webserver was the minor allele in the GSD population and was
significantly associated with IBD. This may again reflect the
selective breeding seen in this breed. Alternatively, it is possible
that the data on the Ensembl webserver does not represent an
accurate report of the major and minor alleles of the general
canine population as the sequence data published is based only on
a small number of breeds (Boxer and Standard Poodle).
In this study, all the SNPs associated with IBD result in a
change in the class of amino acid coded. This may be significant as
it could change the structural properties of the resulting TLR4 or
TLR5 receptor, and therefore alter function. Interestingly, when
the SNPs were protein modelled using the Simple modular
architecture research tool (SMART) web server (http://smart.
embl.de/)[35,36], the location of the majority of these SNPs was
found to be in significant regions. Thus, both the TLR5 T1844C
SNP and TLR4 G1807A SNP were found in the leucine-rich
repeat (LRR) C-terminal domain, which is the region that folds
into an arc or horse-shoe shape to form the ligand binding site in
TLR–receptors [37]. In addition, the TLR4 SNP A1571T was
also found in a LRR region which also contributes to the ligand
Table 5. TLR4 A1571T and TLR4 G1807A genotype association with inflammatory bowel disease in German shepherd dogs.
TLR4 A1571T SNP association with IBD
Model Genotype Control Case OR (95% CI) P-value AIC BIC
Codominant T/T 48 (80%) 38 (70.4%) 1.00 0.0093 154.4 162.6
A/T 12 (20%) 10 (18.5%) 1.05 (0.41–2.70)
A/A 0 (0%) 6 (11.1%) NA (0.00-NA)
Dominant T/T 48 (80%) 38 (70.4%) 1.00 0.23 160.3 165.8
A/T-A/A 12 (20%) 16 (29.6%) 1.68 (0.71–3.98)
Recessive T/T-A/T 60 (100%) 48 (88.9%) 1.00 0.0022 152.4 157.9
A/A 0 (0%) 6 (11.1%) NA (0.00-NA)
Overdominant T/T-A/A 48 (80%) 44 (81.5%) 1.00 0.84 161.7 167.2
A/T 12 (20%) 10 (18.5%) 0.91 (0.36–2.31)
Log-additive --- --- --- 1.99 (0.98–4.01) 0.047 157.8 163.2
TLR4 G1807A SNP association with IBD
Model Genotype Control Case OR (95% CI) P-value AIC BIC
Codominant A/A 48 (80%) 38 (70.4%) 1.00 0.0093 154.4 162.6
A/G 12 (20%) 10 (18.5%) 1.05 (0.41–2.70)
G/G 0 (0%) 6 (11.1%) NA (0.00-NA)
Dominant A/A 48 (80%) 38 (70.4%) 1.00 0.23 160.3 165.8
A/G-G/G 12 (20%) 16 (29.6%) 1.68 (0.71–3.98)
Recessive A/A-A/G 60 (100%) 48 (88.9%) 1.00 0.0022 152.4 157.9
G/G 0 (0%) 6 (11.1%) NA (0.00-NA)
Overdominant A/A-G/G 48 (80%) 44 (81.5%) 1.00 0.84 161.7 167.2
A/G 12 (20%) 10 (18.5%) 0.91 (0.36–2.31)
Log-additive --- --- --- 1.99 (0.98–4.01) 0.047 157.8 163.2
Frequency and significance of the TLR4 A1571T and TLR4 G1807A single nucleotide polymorphism genotype in a case-control association study in German shepherd
dogs (GSDs) with inflammatory bowel disease using a SNaPSHOT multiplex reaction (case=55 unrelated GSDs, control=61 GSDs) (OR-Odds ratio, AIC- Akaike
information criteria, BIC-Bayesian information criteria).
doi:10.1371/journal.pone.0015740.t005
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peptide region when mapped using the SignalP 3.0 web server
(http://www.cbs.dtu.dk/services/SignalP/). The signal peptide is
important in the transport of proteins and a change in the amino
acid may alter the cleavage site and, therefore, may result in a
functional change to the TLR5 receptor [38].
Linkage disequilibrium (LD) in dogs is up to 100 times more
extensive than in human beings [39]. It is therefore, possible that
the associations we found, between SNPs in TLR4 and TLR5 and
the development of IBD, are not the cause of the aberrant
inflammation but are in LD with the causative gene. Functional
analysis of these SNPs will help to confirm if TLR4 and TLR5
play a significant role in the pathogenesis of IBD in GSDs.
However, the role of TLR5 in the pathogenesis of human IBD and
murine colitis has been reported in the literature. TLR5 knockout
mice develop spontaneous colitis and exhibit decreased intestinal
expression of TLR5 [40]. Moreover, deletion of TLR4 rescued the
colitis in these TLR5 knockout mice [40]. In addition, a dominant-
Table 6. TLR5 G22A, TLR5 C100T and TLR5 T1844C genotype association with inflammatory bowel disease in German shepherd
dogs.
TLR5 G22A SNP association with IBD
Model Genotype Control Case OR (95% CI) P-value AIC BIC
Codominant G/G 57(93.4%) 34(61.8%) 1.00 1e-04 147.9 156.2
A/G 4 (6.6%) 20(36.4%) 8.38(2.64–26.59)
A/A 0 (0%) 1 (1.8%) NA (0.00-NA)
Dominant G/G 57(93.4%) 34(61.8%) 1.00 ,0.0001 146.3 151.8
A/G-A/A 4 (6.6%) 21(38.2%) 8.80(2.79–27.81)
Recessive G/G-A/G 61 (100%) 54(98.2%) 1.00 0.22 163 168.5
A/A 0 (0%) 1 (1.8%) NA (0.00-NA)
Overdominant G/G-A/A 57(93.4%) 35(63.6%) 1.00 ,0.0001 147.9 153.4
A/G 4 (6.6%) 20(36.4%) 8.14 (2.57–25.80)
Log-additive --- --- --- 8.51 (2.71–26.70) ,0.0001 145.9 151.5
TLR5 C100T SNP association with IBD
Model Genotype Control Case OR (95% CI) P-value AIC BIC
Codominant C/C 13 (21.3%) 32 (58.2%) 1.00 2e-04 149.5 157.8
C/T 27 (44.3%) 13 (23.6%) 0.20 (0.08–0.49)
T/T 21 (34.4%) 10 (18.2%) 0.19 (0.07–0.52)
Dominant C/T 13 (21.3%) 32 (58.2%) 1.00 ,0.0001 147.5 153
C/T-T/T 48 (78.7%) 23 (41.8%) 0.19 (0.09–0.44)
Recessive C/C-C/T 40 (65.6%) 45 (81.8%) 1.00 0.046 160.5 166
T/T 21 (34.4%) 10 (18.2%) 0.42 (0.18–1.01)
Overdominant C/C-T/T 34 (55.7%) 42 (76.4%) 1.00 0.019 159 164.5
C/T 27 (44.3%) 13 (23.6%) 0.39 (0.17–0.87)
Log-additive --- --- --- 0.41 (0.25–0.68) 3e-04 151.3 156.8
Log-additive --- --- --- 1.99 (0.98–4.01) 0.047 157.8 163.2
TLR5 T1844C SNP association with IBD
Model Genotype Control Case OR (95% CI) P-value AIC BIC
Codominant C/C 12 (19.7%) 27(49.1%) 1.00 0.0024 154.4 162.7
C/T 31 (50.8%) 15 (27.3%) 0.22(0.09–0.54)
T/T 18 (29.5%) 13 (23.6%) 0.32 (0.12–0.86)
Dominant C/C 12 (19.7%) 27 (49.1%) 1.00 7e-04 153.1 158.6
C/T-T/T 49 (80.3%) 28 (50.9%) 0.25 (0.11–0.58)
Recessive C/C-C/T 43 (70.5%) 42 (76.4%) 1.00 0.47 164 169.5
T/T 18 (29.5%) 13 (23.6%) 0.74 (0.32–1.70)
Overdominant C/C-T/T 30 (49.2%) 40 (72.7%) 1.00 0.0091 157.7 163.2
C/T 31 (50.8%) 15 (27.3%) 0.36 (0.17–0.79)
Log-additive --- --- --- 0.54 (0.33–0.89) 0.013 158.4 163.9
Frequency and significance of the TLR5 G22A, TLR5 C100T and TLR5 T1844C single nucleotide polymorphism genotype in a case-control association study in German
shepherd dogs (GSDs) with inflammatory bowel disease using a SNaPSHOT multiplex reaction (case=55 unrelated GSDs, control=61 GSDs; 47 GSDs with non-
inflammatory disease and 14 healthy GSDs) (OR-Odds ratio, AIC- Akaike information criteria, BIC-Bayesian information criteria).
doi:10.1371/journal.pone.0015740.t006
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people of Jewish ethnicity against Crohn’s disease (CD) [34]. It
could be speculated that patients having the TLR5 stop
polymorphism may also have a mutated TLR4 thus protecting
them from IBD. Moreover, In CD patients, tolerance to
commensal derived flagellin is lost and serum reactivity to flagellin
can be demonstrated [41]. In addition, TLR5 signalling has been
shown to play a role in defensin production [42]. One study
showed that TLR5 uses gangliosides as co-receptors to bind
flagellin leading to increased human beta defensin-2 expression in
human colon adenocarcinoma (Caco)-2 cells [43]. This demon-
strates that TLR5 activation may be needed for secretion of
certain defensins. The reduced gene copy number of the beta-
defensin cluster seen in CD patients may therefore be due to
aberrant TLR5 activation [44,45]. Clearly, evidence has accumu-
lated that dysregulated TLR5 function may play a role in the
pathogenesis of human IBD.
Similarly, several studies have looked at the role of TLR4 in
human IBD. TLR4 expression is up-regulated in both Crohn’s
disease (CD) and ulcerative colitis (UC) [10,11]. In paediatric IBD
patients, higher levels of TLR4 mRNA and protein were found in
the inflamed colonic mucosa [12]. This confers with our findings
in canine IBD [15,16], and specifically in GSDs [17]. Epidemi-
ological studies have also shown an association between TLR4
polymorphism and susceptibility to IBD in people. A Belgian
cohort found that the allele frequency of the TLR4 A299G
polymorphism was significantly higher in CD and UC patients
[21]. Furthermore, the A299G SNP has been shown to be
associated with reduced responsiveness following lipopolysaccha-
ride stimulation [46]. Another TLR4 polymorphism, T399IL, was
exclusively associated with UC but not CD [22].
Of the six dogs in the case population that harboured the TLR4
SNPs in a recessive genotype, five of them also had the risk
haplotype for all three TLR5 SNPs (ACC). This suggests that the
TLR4 SNPs may need to be present with the TLR5 SNPs in order
for them to have a significant effect. It is known that TLR4 and
TLR5 are able to form heterodimeric complexes and this
enhances the diversity of the response to flagellin [47]. Therefore,
the functional consequence of the TLR4 mutations may be acting
via TLR5 signalling and so having both TLR4 and TLR5 SNPs
may affect intracellular signalling after ligation of flagellin more
than just the TLR5 SNPs on their own.
Our results from the mutational analysis showed that no TLR2
non-synonymous SNPs could be identified in the coding region of
the gene. This finding is also mirrored in the literature as there are
no published or identified non-synonymous SNPs in the canine
TLR2 exon gene. Moreover, we could not detect upregulation of
TLR2 mRNA in intestinal biopsies in GSDs with IBD [17].
However, the role of TLR2 in canine IBD cannot be completely
eliminated as some studies, including dogs of many different
breeds, have shown an up-regulation at the mRNA level in dogs
with chronic enteropathies [15,16]. This could be due to SNPs
present in the promoter region of the TLR2 gene which was not
investigated in this study or could be a consequence of the disease
process rather than the cause.
One potential limitation of this study may be the selection and
inclusion of controls having non-inflammatory disease. Although
retrospective phenotyping was carried out to ensure that none of
these dogs had inflammatory, infectious or immune-mediated
disease, this type of inquiry can be imprecise and therefore may
have led to some GSDs inappropriately being included in the
control group as they may have later developed these diseases.
However, to control for this, GSDs older than 4 years were
recruited as controls and 75% of dogs in our control group were 5
years or older. This resulted in a significant difference in the age
groups between the case and control population. However, we did
have 14 completely healthy dogs in our control group, who were
all over the age of 4 years and none of these dogs had the TLR5
risk haplotype (ACC) nor the two TLR4 recessive SNPs, further
supporting the role of these SNPs in canine IBD in GSDs. Another
potential limitation of this study was that the degree of relatedness
of the dogs could not be assessed as most of these dogs were not
registered with the UK Kennel Club. This may have skewed the
results; however, none of the dogs belonged to the same litter.
Previous studies have shown that the GSD breed is one of the most
diverse dog breeds as it has retained a large range of Dog
Leucocyte Antigen (DLA) haplotypes and therefore represents a
breed that has been less selectively in-bred than other dog breeds
[48]. Moreover, we have shown in a previous study that the same
Figure 1. Linkage disequilibrium of single nucleotide polymor-
phisms in canine TLR4. Linkage disequilibrium plot of the four non-
synonymous TLR4 single nucleotide polymorphisms in the German
shepherd dog (GSD) population obtained from a case-control
association study of inflammatory bowel disease. Sequencing informa-
tion was obtained using a SNaPSHOT multiplex reaction (case=55
unrelated GSDs, control=61 GSDs).
doi:10.1371/journal.pone.0015740.g001
Figure 2. Linkage disequilibrium of single nucleotide polymor-
phisms in canine TLR5. Linkage disequilibrium plot of the three non-
synonymous TLR5 SNPs in the German shepherd dog (GSD) population
obtained from a case-control association study of inflammatory bowel
disease. Sequencing information was obtained using a SNaPSHOT
multiplex reaction (case=55 unrelated GSDs, control=61 GSDs).
doi:10.1371/journal.pone.0015740.g002
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anal furunculosis in GSDs, which is another immune-mediated
disease commonly seen in this breed. [28]
In conclusion, we have identified an association between three
non-synonymous SNPs in the TLR5 gene (G22A, C100T and
T1844C) and two non-synonymous SNPs in the TLR4 gene
(A1571T and 1807A) with IBD in the GSD population. Studying
the functional significance of these SNPs will not only help to
confirm their importance in IBD but will also help to increase our
understanding of the pathogenesis of these diseases in dogs and in
man. In addition, as the pathogenesis of IBD is multifactorial,
studying the nutrition and maintenance conditions of dogs with
and without the mutations may help determine key triggering
factors in the intestinal microbiota that are responsible for bringing
about these changes and may therefore allow the development of
preventative strategies not only in the dog but also in people.
Materials and Methods
Ethics Statement
Ethics approval for the recruitment of healthy German
shepherd dogs was sought and approved from the Ethics
Committee at the Royal Veterinary College (URN 2010 1035).
Sample population
The case population included 55 GSDs; 38 were diagnosed
with inflammatory bowel disease at the Royal Veterinary College,
UK and 17 at the Small Animal Teaching Hospital, University of
Liverpool, UK. For all cases, the diagnostic work-up was
reviewed. All cases had complete medical records consisting of
a detailed history at first examination and at subsequent re-
examinations, haematology and biochemistry results, detailed
abdominal ultrasonography report and detailed histopathology
reports. All known causes of gastrointestinal inflammation
including enteropathogenic bacteria were ruled out by routine
haematology and biochemistry, faecal analysis, ultrasound and
measurement of serum trypsin-like immunoreactivity concentra-
tion. Definitive diagnosis of IBD was based on histological
evidence of an inflammatory infiltrate within the lamina propria
of endoscopically obtained intestinal biopsies.
The control population consisted of 47 unrelated GSDs from
the UK. These were retrospectively phenotyped, either by owner
or veterinary surgeon telephone contact, to ensure they had no
inflammatory, immune-mediated or infectious disease. Fourteen
additional GSDs were also included in the control group; six of
these were enrolled from the blood donor programme at the RVC
and eight were recruited exclusively for the study. Ethics approval
was granted from the Royal Veterinary College, UK for the
recruitment of these eight dogs.
Blood stored in Ethylenediaminetetraacetic acid (EDTA) was
collected from the DNA archive for those cases that were seen at
the RVC. For the cases from Liverpool, paraffin sections of
intestinal tissue were available. Residual blood from the blood
donor dogs and from the eight dogs following collection of blood
for folate and cobalamin concentrations as a screening test for
intestinal health were collected into EDTA tubes.
Mutational Analysis of TLR2/TLR4 and TLR5 genes
A mutational analysis of the TLR2, TLR4 and TLR5 exons was
carried out, in 10 GSDs diagnosed with IBD, to determine the
presence and frequency of non-synonymous SNPs in the coding
regions of the genes, so that these could be investigated further in a
case-control association study to determine their significance in
IBD in the GSD population.
Ten cases of GSDs with IBD were selected from the 38
diagnosed at the RVC and genomic DNA was extracted from
blood stored in EDTA using the Qiagen DNeasy blood and tissue
kit (Qiagen, Crawley, UK) according to the manufacturer’s
protocol.
Full-length canine TLR2, TLR4 and TLR5 forward and
reverse primers were designed using the Integrated DNA
technology oligoanalyzer 3.1 programme (http://eu.idtdna.com/
analyzer/Applications/OligoAnalyzer) (Table 7) based on the full
sequences for canine TLR2, TLR4 and TLR5.
Easy A 2X master mix (Stratagene, California, USA) was used
for polymerase chain reaction (PCR) with reactions heated to
95uC for 10 min, followed by 30 cycles of 95uC for 1 min, 55uC
for 1 min and 72uC for 3 mins then a further 72uC for 7 mins.
Full-length PCR products were electrophoresed with 6X orange
loading dye (Fermentas, UK) on a 1% agarose/safeview nucleic
stain (NBS Biologicals, Huntington, UK) gel in 1X Tris-Borate
EDTA (TBE) buffer using the power pack FB 300 (Fischer
Scientific, UK). The gels were visualised under UV light
(Ultraviolet Transilluminator, UVP, California,USA), and the
bands cut out and placed into separate eppendorf tubes. DNA was
extracted using the Qiagen mini-elute extraction kit (Qiagen,
Crawley, UK), according to manufacturer’s instructions.
Table 7. Primers used in mutational analysis of TLR4 and TLR5.
Primer Manufacturer Direction Primer sequence
Full-length TLR2 MWG Biotech (London, UK) Forward 59-GGA CAA TGT CAC GTG TTT TG-39
Reverse 59-CGA ATC TAG GAT TTT ATT GCT GT-39
Full-length TLR5 MWG Biotech (London, UK) Forward 59-TTT CCG TCC CGC AGG ATC ATG-39
Reverse 59-ACC CGT GCA AAT GGC AAG AG-39
Full-length TLR4 MWG Biotech (London, UK) TLR4 Exon 1 Forward 59-TTC CTC TTG CCC CTT AA CTC-39
Reverse 59-GCC ATG TAA CCA TGA ACT GT-39
TLR4 Exon 2 Forward 59-GAT GGA TGG ATG GAC AGA CC-39
Reverse 59-TTC ACA GAT GAG GCA ATG GG-39
TLR4 Exon 3 Forward 59-ATA CTG AAT CTG TGG GGC TT-39
Reverse 59-ATT TGG TGG AAG CAT CCA CCT-39
Primers used in the TLR2/TLR4 and TLR5 mutational analysis.
doi:10.1371/journal.pone.0015740.t007
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bridge, UK for sequencing using sequencing primers specifically
designed to cover the entire sequence of the exons (Table 8).
Sequence data was compared to the canine genome (www.
ensembl.org/Canis_familiaris) and CLC DNA Workbench version
5.1 (CLC Bio) used to identify non-synonymous SNPs present in
the genes.
Determining the allele frequency of TLR4 and TLR5 SNPs
in healthy GSDs and those affected with IBD using
SNaPSHOT multiplex reaction
Non-synonymous SNPs identified by mutational analysis in the
TLR2, TLR4 and TLR5 exon genes were analysed further in a
case population consisting of 55 GSDs with IBD and a control
population consisting of 61 GSDs; 47 with non-inflammatory
disease and 14 healthy. Genotyping of all SNPs was carried out by
primer extension using the ABI PRISM SNaPSHOT Multiplex
Kit (Applied Biosystems).
Genomic DNA was extracted from blood stored in EDTA from
the remainder of the 28 IBD cases seen at the RVC and from the
61 control GSDs using the Qiagen DNeasy blood and tissue kit
(Qiagen, Crawley, UK) according to the manufacturer’s protocol.
This kit along with the manufacturer’s recommendations was also
used to extract genomic DNA from the paraffin sections from the
17 cases diagnosed with IBD at the University of Liverpool.
PCR was carried out on all samples using amplification primers
to yield a fragment size containing the SNPs that was less than
1200 base pairs (Table 9). Immolase DNA polymerase (Bioline,
London, UK) was used for PCR with reactions heated to 95uC for
10 min, followed by 35 cycles if 95uC for 1 min, 52uC for 1 min
and 72uC for 2 mins, then a further 72uC for 7 mins.
Five micro-litres of PCR product from each sample was added
to 2 mL of ExoSAP-IT (United States Biochemical (USB), USA)
and mixed thoroughly and incubated for an hour at 37uC and
then at 75uC for 15 minutes.
Sequencing primers of different lengths for the SNaPSHOT
reaction were designed to stop just one base before the SNP
(Table 10). All SNaPSHOT primers were diluted to give a
concentration of 0.2 mL as a working solution. For multiplexing
0.2 mM concentration of each primer was used.
Table 8. Sequencing primers used in mutational analysis of TLR4 and TLR5.
Manufacturer Primer Sequence
TLR2 MWG Biotech (London, UK) TLR2 forward 59-GGA CAA TGT CAC GTG TTT TG-39
TLR2 internal forward 59-CAT TTG GAC ACT TTC CAC-39
TLR2 internal reverse 59-AAG ACT TTG GCC AGT GCT-39
TLR2 reverse 59-CGA ATC TAG GAT TTT ATT GCT GT-39
TLR5 MWG Biotech (London, UK) TLR5 forward 59-TTT CCG TCC CGC AGG ATC ATG-39
TLR5 internal forward 59-AGA CCC TGG ACG TGT CTA A-39
TLR5 internal reverse 59-CCA TGG AGA CAG AGG ACA-39
TLR5 reverse 59-ACC CGT GCA AAT GGC AAG AG-39
TLR4 MWG Biotech (London, UK) Exon 1 TLR4 exon 1 forward 59-TTC CTC TTG CCC CTT AA CTC-39
TLR4 exon 1 reverse 59-GCC ATG TAA CCA TGA ACT GT-39
Exon 2 TLR4 exon 2 forward 59-GAT GGA TGG ATG GAC AGA CC-39
TLR4 exon 2 reverse 59-TTC ACA GAT GAG GCA ATG GG-39
Exon 3 TLR4 exon 3 forward 59-ATA CTG AAT CTG TGG GGC TT-39
TLR4 exon 3 internal forward 59-GGT CTG GCT GGC TTA AAG-39
TLR4 exon 3 internal reverse 59-CAA CTT CCA CCA AGA GCT G-39
TLR4 exon 3 reverse 59-ATT TGG TGG AAG CAT CCA CCT-39
Sequencing primers used in TLR2/TLR4 and TRL5 mutational analysis.
doi:10.1371/journal.pone.0015740.t008
Table 9. Fragment amplification primers used in SNaPSHOT reaction of TLR4 and TLR5.
Amplification primer Manufacturer Forward sequence Reverse sequence
TLR4 Frag 1 (containing SNP
T23C)
MWG Biotech (London, UK) 59-TCC CTC TTG CCC CTT AA CTC-39 59-GCC ATG TAA CCA TGA ACT GT-39
TLR4 Frag 2 (containing SNP
G1039A, A1571T and G1807A)
MWG Biotech (London, UK) 59-TCA AGG TCT GGC TGG CTT-39 59-CCA CAG GAG CTT TTC ATC-39
TLR5 Frag 1 (containing SNP
G22A and C100T)
MWG Biotech (London, UK) 59-GAT TGA GTG ACG GCA AAC-39 59-CCT GTT GAT CTT GTT GTG-39
TLR5 Frag 2 (containing SNP
T1844C)
MWG Biotech (London, UK) 59-ACA ACA AGT TCA TCT GCG-39 59-CTC CTC GAA GCA CAG GTT-39
TLR4 and TLR5 fragment amplification primers used in SNaPSHOT reaction.
doi:10.1371/journal.pone.0015740.t009
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Biosystems) was thawed on ice. For each reaction the following
was added to a 96-well plate: 4 mL undiluted DNA ExoSAP-IT
cleaned template, 1 mL SNaPSHOT SNP primer mix, 2 mL
SNaPSHOT reagent mix, 2 mL sequencing buffer (ABI prisms,
Applied Biosystems) and 1 mL MWB.
The plate was incubated at 96uC for 10 seconds, 50uC for 5
seconds and at 60uC for 30 seconds. This was repeated for 25
cycles.
Once the sequencing reaction was complete the samples were
removed from the thermal cycler and 1 mL of shrimp alkaline
phosphatase (SAP) (USB, USA) was added to each well. The plate
was then incubated at 37uC for one hour and the enzyme
deactivated by incubating at 75uC for 15 minutes.
A master mix was made up per reaction well of 9.0 mL Hi-Di
Formamide (ABI prisms, Applied Biosystems) and 0.5 mL Gene-
Scan 120 Liz size standard (ABI prisms, Applied Biosystems). Half
a micro-litre of SAP cleaned SNaPSHOT product was aliquotted
into a red fisher plate (Fisher Scientific, UK). Nine and a half
micro-litres of master mix was added to each well. The plate was
covered with a 96 well grey septa and spun briefly in a centrifuge.
The plate was then denatured at 95uC for 3 minutes and snap
cooled on ice for 5 minutes and placed in ABI Prism 3100 genetic
analyzer for electrophoresis.
Electrophoresis results were analysed using Genemapper
(version 3.2.1) software (Applied Biosytems). Allele frequency,
association and linkage disequilibrium data for all the SNPs were
statistically assessed using Haploview software package (version
4.1; http://www.broad.mit.edu/personal/jcbarret/haplo/). The
calculation of Hardy-Weinberg equilibrium and further genotype
and haplotype associations for all the SNPs were carried out using
SNPSTATS programme (http://bioinfo.iconcologia.net/index.
php?module=Snpstats). Statistical significance was set at P,0?05.
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